Skip to main content

Independent service, not a government website.

Federal grantForecast (not open yet)Grant forecast

Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Department of Health and Human Services, Food and Drug Administration

Forecast: posting date not announced yet

This is a Grants.gov forecast: the agency plans to post this funding opportunity, but applications are not open yet. Dates and amounts are the agency's estimates and can change. When it is posted on Grants.gov, this page updates to the posted grant.

Forecast details

Status
Forecast: posting date not announced yet
Estimated post date
Not stated
Estimated application due date
Not stated
Estimated award date
Not stated
Estimated project start
Not stated
Fiscal year
2024
Forecast posted
Nov 24, 2023
Funding opportunity number
FOR-FD-24-010
Grants.gov ID
351137
Funding instrument
Cooperative Agreement
Category of funding
Agriculture, Consumer Protection, Food and Nutrition
Opportunity category
Discretionary
Award ceiling
$2,000,000 (estimate)
Award floor
$2,000,000 (estimate)
Total program funding
Not stated
Expected awards
1
Cost sharing required
No
Assistance Listing (ALN/CFDA)
  • 93.103 — Food and Drug Administration Research

Who can apply

Businesses are among the eligible applicants listed on Grants.gov.

  • Private institutions of higher education
  • Special district governments
  • Public housing authorities/Indian housing authorities
  • Native American tribal organizations (other than Federally recognized tribal governments)
  • State governments
  • City or township governments
  • Native American tribal governments (Federally recognized)
  • Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
  • Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
  • For profit organizations other than small businesses
  • Others (see text field entitled "Additional Information on Eligibility" for clarification)
  • Independent school districts
  • Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
  • County governments
  • Public and State controlled institutions of higher education
  • Small businesses

Additional information on eligibility

Applicant organizations may submit more than one application, provided that each application is scientifically distinct. The FDA will not accept duplicate or highly overlapping applications under review at the same time per 2.3.7.4 Submission of Resubmission Application. This means that the FDA will not accept:•A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.•A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.•An application that has substantial overlap with another application pending appeal of initial peer review (see 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.

Description

Announcement and documents

No attachments listed in the Grants.gov data. Check the official listing for documents.

Grantor contact

The agency contact for this forecast is listed on the official Grants.gov forecast. We don't copy personal contact details from forecasts.

Grants: Grants.gov (federal grant opportunities) · last updated Nov 20, 2026, 4:20 PM ET.

This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.

Always confirm details, amendments and deadlines on the official listing. Government Bid Finder is an independent service and is not affiliated with or endorsed by the U.S. government.